What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?

Published:2016-10-20 Issue:11 Volume:9 Page:1403-1411
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Atzeni Fabiola¹,Benucci Maurizio²,Talotta Rossella¹,Masala Ignazio Francesco³,Sarzi-Puttini Piercarlo¹,Govoni Marcello⁴

Affiliation:

1. Rheumatology Unit, L. Sacco University Hospital, Milan, Italy

2. Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy

3. Orthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy

4. Rheumatology Unit, S. Anna Hospital University of Ferrara, Ferrara, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2016.1234374

Reference46 articles.

1. Rheumatoid arthritis

2. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

4. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recomendaciones SER sobre la gestión de riesgo del tratamiento con FAME biológicos o sintéticos dirigidos en pacientes con artritis reumatoide;Reumatología Clínica;2023-12

2. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis;Reumatología Clínica (English Edition);2023-12

3. Tapering and withdrawal in patients with rheumatoid arthritis in stable remission;The Lancet Rheumatology;2021-11

4. Systemic rheumatic diseases: From biological agents to small molecules;Autoimmunity Reviews;2019-06

5. JAK3-selective inhibitor peficitinib for the treatment of rheumatoid arthritis;Expert Review of Clinical Pharmacology;2019-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3